Joseph Ashwal, MD, knew a good deal when he saw one.
The family physician wanted to take the lead on starting a patient-centered medical home (PCMH) model for his 25-physician practice in Frederick, Md., after reading a nearly 100-page treatise from the area's largest private payer.
The program from CareFirst BlueCross BlueShield -- like so many others -- would pay a bonus for spending extra time with their sicker patients. The money would cover a care coordinator nurse to help oversee these patients' care.
That nurse would help identify the practice's most needy patients, help develop a care plan with their physician, and ensure that the patient saw it through.
"That nurse does a lot of work so the physicians don't have to do it," Ashwal told MedPage Today.
The program -- the Total Care and Cost Improvement Program -- has been a game-changer for Ashwal and his practice, Frederick Primary Care Associates, yielding more than a 20% increase in payments from CareFirst last summer for the group's success during 2011 in lowering spending by keeping patients out of the hospital and emergency departments.
Read the full story here: http://bit.ly/14eaA5m
Source: MedPage Today
Eculizumab Biosimilar ABP 959 Demonstrates Similarity to Reference in Patients With PNH
December 6th 2023ABP 959, an eculizumab biosimilar in development, has demonstrated similar efficacy and pharmacokinetics to the reference product for patients with paroxysmal nocturnal hemoglobinuria (PNH), according to research at the 2023 American Society of Hematology Annual Meeting.
Read More
Humana Report Shows Benefits of Value-Based Care for Patients, Physicians
December 6th 2023Patients seen at value-based care clinics received more preventive screenings and had lower risks of hospitalization and emergency room visits, according to Humana’s 10th annual value-based care report.
Read More
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More